Intensity Modulated Radiation Therapy for Anal Cancer: Dosimetric Comparison, Acute Toxicity Profile, and Quality of Life Assessment

PrintE-mail
Title Intensity Modulated Radiation Therapy for Anal Cancer: Dosimetric Comparison, Acute Toxicity Profile, and Quality of Life Assessment
Contact N/A
Principal Investigator David Mattson, MD
Study Number 128808
Summary To determine the effect on quality of life for patients with anal cancer that had received administration of Intensity Modulation Radiation Therapy (IMRT). A quality of life questionnaire will assess the patients quality of life before, during and following completion of treatment.
Eligibility
  • Histopathology proven squamous cell carcinoma of the anal canal since January 1, 2005
  • Patient received IMRT with concurrent chemotherapy, and not enrolled on RTOG 0529